It is therefore interesting that high expression of GRAMD1C and GRAMD2B was found to associate with improved survival of ccRCC patients, while the opposite was found for GRAMD1A and GRAMD1B. Here, GRAMD1C is linked to nonpapillary renal cell carcinoma.